123 related articles for article (PubMed ID: 38804222)
21. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
[TBL] [Abstract][Full Text] [Related]
22. Procalcitonin and Midregional Proatrial Natriuretic Peptide as Markers of Ischemic Stroke: The Northern Manhattan Study.
Katan M; Moon YP; Paik MC; Mueller B; Huber A; Sacco RL; Elkind MS
Stroke; 2016 Jul; 47(7):1714-9. PubMed ID: 27197849
[TBL] [Abstract][Full Text] [Related]
23. N-terminal probrain natriuretic peptide as a biomarker of cardioembolic stroke.
Fonseca AC; Matias JS; Pinho e Melo T; Falcão F; Canhão P; Ferro JM
Int J Stroke; 2011 Oct; 6(5):398-403. PubMed ID: 21645267
[TBL] [Abstract][Full Text] [Related]
24. 4-Hydroxyl-2-Nonenal Localized Expression Pattern in Retrieved Clots is Associated with Large Artery Atherosclerosis in Stroke Patients.
Osakada Y; Yamashita T; Morihara R; Matsumoto N; Sasaki R; Tadokoro K; Nomura E; Kawahara Y; Omote Y; Hishikawa N; Takemoto M; Ohta Y; Suruga Y; Nagase T; Takasugi Y; Inoue S; Watanabe K; Deguchi K; Tokunaga K; Sasada S; Kobayashi K; Maeoka R; Fukutome K; Takahashi K; Ohnishi H; Kuga Y; Ohnishi H; Abe K
J Stroke Cerebrovasc Dis; 2021 Mar; 30(3):105583. PubMed ID: 33412400
[TBL] [Abstract][Full Text] [Related]
25. Prognosis of ischemic stroke patients with both aortic atheroma and cardioembolic sources.
Jung JW; Baik M; Jeong J; Lee IH; Kim KH; Yun J; Shim CY; Hong GR; Kim YD; Heo JH; Nam HS
Sci Rep; 2024 Jun; 14(1):12656. PubMed ID: 38825610
[TBL] [Abstract][Full Text] [Related]
26. Midregional Pro-Atrial Natriuretic Peptide and Atrial Fibrillation: Interesting Association or Practice Changing?
Piccini JP; Harrington J
J Am Coll Cardiol; 2022 Apr; 79(14):1382-1384. PubMed ID: 35393019
[No Abstract] [Full Text] [Related]
27. Distribution of atrial cardiomyopathy markers and association with atrial fibrillation detected after ischaemic stroke in the SAFAS study.
Didier R; Garnier L; Duloquin G; Meloux A; Sagnard A; Graber M; Dogon G; Benali K; Pommier T; Laurent G; Vergely C; Bejot Y; Guenancia C
Stroke Vasc Neurol; 2024 Apr; 9(2):165-173. PubMed ID: 37429637
[TBL] [Abstract][Full Text] [Related]
28. High serum levels of pro-brain natriuretic peptide (pro BNP) identify cardioembolic origin in undetermined stroke.
Rodríguez-Yáñez M; Sobrino T; Blanco M; de la Ossa NP; Brea D; Rodríguez-González R; Leira R; Dávalos A; Castillo J
Dis Markers; 2009; 26(4):189-95. PubMed ID: 19729800
[TBL] [Abstract][Full Text] [Related]
29. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in the diagnosis of heart failure.
Potocki M; Breidthardt T; Reichlin T; Hartwiger S; Morgenthaler NG; Bergmann A; Noveanu M; Freidank H; Taegtmeyer AB; Wetzel K; Boldanova T; Stelzig C; Bingisser R; Christ M; Mueller C
J Intern Med; 2010 Jan; 267(1):119-29. PubMed ID: 19570053
[TBL] [Abstract][Full Text] [Related]
30. The prognostic value of midregional proatrial natriuretic peptide in patients with hemorrhagic stroke.
Fischer M; Katan M; Morgenthaler NG; Seiler M; Müller B; Lackner P; Errath M; Helbok R; Pfausler B; Beer R; Schmutzhard E; Broessner G
Cerebrovasc Dis; 2014; 37(2):128-33. PubMed ID: 24481415
[TBL] [Abstract][Full Text] [Related]
31. Trends, Predictors and Outcomes of Ischemic Stroke Among Patients Hospitalized with Takotsubo Cardiomyopathy.
Abe T; Olanipekun T; Igwe J; Khoury M; Busari O; Musonge-Effoe J; Valery E; Egbuche O; Mather P; Ghali J
J Stroke Cerebrovasc Dis; 2021 Oct; 30(10):106005. PubMed ID: 34332228
[TBL] [Abstract][Full Text] [Related]
32. Moderate Levels of N-Terminal Pro-B-Type Natriuretic Peptide is Associated with Increased Risks of Total and Ischemic Strokes among Japanese: The Circulatory Risk in Communities Study.
Ebihara K; Yamagishi K; Umesawa M; Muraki I; Cui R; Imano H; Kubota Y; Hayama-Terada M; Shimizu Y; Ohira T; Sankai T; Okada T; Kitamura A; Kiyama M; Iso H;
J Atheroscler Thromb; 2020 Aug; 27(8):751-760. PubMed ID: 31932552
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic and Prognostic Value of Left Atrial Function in Identification of Cardioembolism and Prediction of Outcomes in Patients with Cryptogenic Stroke.
Bhat A; Chen HHL; Khanna S; Mahajan V; Gupta A; Burdusel C; Wolfe N; Lee L; Gan GCH; Dobbins T; MacIntyre CR; Tan TC
J Am Soc Echocardiogr; 2022 Oct; 35(10):1064-1076. PubMed ID: 35691457
[TBL] [Abstract][Full Text] [Related]
34. The Investigation of Left Atrial Structure and Stroke Etiology: The I-LASER Study.
Johansen MC; Doria de Vasconcellos H; Nazarian S; Lima JAC; Gottesman RF
J Am Heart Assoc; 2021 Jan; 10(2):e018766. PubMed ID: 33442991
[TBL] [Abstract][Full Text] [Related]
35. Assessment of the manifestations of atrial fibrillation in patients with acute cerebral stroke - a single-center study based on 998 patients.
Warmus P; Niedziela N; Huć M; Wierzbicki K; Adamczyk-Sowa M
Neurol Res; 2020 Jun; 42(6):471-476. PubMed ID: 32241245
[No Abstract] [Full Text] [Related]
36. Blood biomarkers to detect new-onset atrial fibrillation and cardioembolism in ischemic stroke patients.
Harpaz D; Bajpai R; Ng GJL; Soljak M; Marks RS; Cheung C; Arumugam TV; Quek AML; Tok AIY; Seet RCS
Heart Rhythm; 2021 Jun; 18(6):855-861. PubMed ID: 33561586
[TBL] [Abstract][Full Text] [Related]
37. Pro-atrial natriuretic peptide and prediction of atrial fibrillation and stroke: The Malmö Preventive Project.
Berntsson J; Smith JG; Nilsson PM; Hedblad B; Melander O; Engström G
Eur J Prev Cardiol; 2017 May; 24(8):788-795. PubMed ID: 28195503
[TBL] [Abstract][Full Text] [Related]
38. Plasma natriuretic peptides and incidence of subtypes of ischemic stroke.
Berntsson J; Zia E; Borné Y; Melander O; Hedblad B; Engström G
Cerebrovasc Dis; 2014; 37(6):444-50. PubMed ID: 25060145
[TBL] [Abstract][Full Text] [Related]
39. Brain Natriuretic Peptide and Particular Left Ventricle Segment Asynergy Associated with Cardioembolic Stroke from Old Myocardial Infarction.
Hosomi N; Yoshimoto T; Kanaya Y; Neshige S; Hara N; Himeno T; Kono R; Takeshima S; Takamatsu K; Ota T; Miyamoto Y; Yasuda K; Shimoe Y; Ota T; Kuriyama M; Matsumoto M
J Stroke Cerebrovasc Dis; 2016 May; 25(5):1165-1171. PubMed ID: 26922130
[TBL] [Abstract][Full Text] [Related]
40. Comparison of midregional pro-A-type natriuretic peptide and the N-terminal pro-B-type natriuretic peptide for predicting mortality and cardiovascular events.
van Hateren KJ; Alkhalaf A; Kleefstra N; Groenier KH; de Jong PE; de Zeeuw D; Gans RO; Struck J; Bilo HJ; Gansevoort RT; Bakker SJ
Clin Chem; 2012 Jan; 58(1):293-7. PubMed ID: 21948291
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
